Detalhe da pesquisa
1.
Macrophages impede CD8 T cells from reaching tumor cells and limit the efficacy of anti-PD-1 treatment.
Proc Natl Acad Sci U S A;
115(17): E4041-E4050, 2018 04 24.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29632196
2.
cAMP Bursts Control T Cell Directionality by Actomyosin Cytoskeleton Remodeling.
Front Cell Dev Biol;
9: 633099, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34095108
3.
Local IFNα enhances the anti-tumoral efficacy of systemic anti-PD1 to prevent tumor relapse.
J Immunother Cancer;
8(2)2020 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33239415
4.
TGFß blocks IFNα/ß release and tumor rejection in spontaneous mammary tumors.
Nat Commun;
10(1): 4131, 2019 09 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31511510
5.
The STING agonist DMXAA triggers a cooperation between T lymphocytes and myeloid cells that leads to tumor regression.
Oncoimmunology;
6(10): e1346765, 2017.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29123960
6.
Vaccine-induced tumor regression requires a dynamic cooperation between T cells and myeloid cells at the tumor site.
Oncotarget;
6(29): 27832-46, 2015 Sep 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26337837
7.
Early T cell signalling is reversibly altered in PD-1+ T lymphocytes infiltrating human tumors.
PLoS One;
6(3): e17621, 2011 Mar 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-21408177